Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Payables (2016 - 2025)

DarioHealth filings provide 14 years of Payables readings, the most recent being $5.3 million for Q4 2025.

  • On a quarterly basis, Payables rose 72.45% to $5.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 72.45% increase, with the full-year FY2025 number at $5.3 million, up 72.45% from a year prior.
  • Payables hit $5.3 million in Q4 2025 for DarioHealth, up from $4.5 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $7.2 million in Q3 2021 to a low of $1.1 million in Q4 2023.
  • Median Payables over the past 5 years was $4.2 million (2022), compared with a mean of $4.3 million.
  • Biggest five-year swings in Payables: surged 433.33% in 2021 and later plummeted 82.84% in 2023.
  • DarioHealth's Payables stood at $5.1 million in 2021, then rose by 29.03% to $6.6 million in 2022, then plummeted by 82.84% to $1.1 million in 2023, then soared by 169.23% to $3.0 million in 2024, then skyrocketed by 72.45% to $5.3 million in 2025.
  • The last three reported values for Payables were $5.3 million (Q4 2025), $4.5 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.